Medication-Assisted Treatment (MAT) and Medications for Opioid Use Disorder (MOUD) have focused heavily on methadone and buprenorphine. This post explores why naltrexone, a non-opioid antagonist, may be better understood as “Medication-Assisted Prevention” and why elevating its role could be critical to reducing opioid overdose deaths.